Announcements Trials

Browse Landscape

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 4 Stomach Neoplasms 3 Uterine Cervical Neoplasms 1 Smoking 1 Recurrence 1 Pulmonary Disease, Chronic Obstructive 1 Platelet Glycoprotein IV Deficiency 1 Pediatric Brain Tumor 1 Pancreatic Cyst 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroendocrine Tumors 1 Neoplasms 1 Melanoma 1 Lymphoma 1 Locally Advanced Pancreatic Cancer 1 Gastrointestinal Neoplasms 1 Fatty Liver 1 Cysts 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Anus Neoplasms 1 Adenocarcinoma 1

Interventions

Bevacizumab 40 Paclitaxel 35 Carboplatin 28 pembrolizumab 21 Cyclophosphamide 15 Specimen Handling 14 Cisplatin 13 olaparib 11 Blood Specimen Collection 11 niraparib 10 fludarabine 10 Magnetic Resonance Spectroscopy 9 Drug Therapy 9 liposomal doxorubicin 8 Topotecan 8 Taxes 8 Gemcitabine 8 Biopsy 8 Fulvestrant 7 Doxorubicin 6 cemiplimab 5 abemaciclib 5 Surveys and Questionnaires 5 Standard of Care 5 Injections 5 Fluorouracil 5 Cytoreduction Surgical Procedures 5 trastuzumab deruxtecan 4 mirvetuximab soravtansine 4 aldesleukin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ovarian Neoplasms × Tomography, X-Ray Computed × Clear all

NCT06331130 2025-03-12

MIO

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡